Reduction of myocardial infarct size by a fluorocarbon-oxygenated reperfusate
- 1 February 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 53 (4) , 608-613
- https://doi.org/10.1016/0002-9149(84)90039-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining techniquePublished by Elsevier ,2004
- Intracoronary thrombolysis in acute myocardial infarction: Correlations among serum enzyme, scintigraphic and hemodynamic findingsThe American Journal of Cardiology, 1982
- Effects of nonsurgical coronary reperfusion on the left ventricle in human subjects compared with conventional treatment: Study of 18 patients with acute myocardial infarction treated with intracoronary infusion of streptokinaseThe American Journal of Cardiology, 1982
- Fluosol-Da: An Artificial Blood for Total Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1981
- The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion.Circulation, 1980
- Differentiation between reperfusion and occlusion myocardial necrosis with technetium-99m pyrophosphate scansThe American Journal of Cardiology, 1980
- Cellular calcium and cardiac cell deathThe American Journal of Cardiology, 1979
- Characterization of the “border zone” in acute regional ischemia in the dogThe American Journal of Cardiology, 1977
- Myocardial reperfusion in acute experimental ischemia. Beneficial effects of prior treatment with steroids.Circulation, 1976
- The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the DogJournal of Clinical Investigation, 1974